Pro UKPro AUPro CA Pro HK FMoney StockTube Mining Capital Oil Capital Tech Capital Biotech Capital CN
Sign up USA
Proactive Investors - Run By Investors For Investors

OncoCyte releases positive data on lung cancer diagnostic study

OncoCyte Corporation (NYSE:OCX) CEO William Annett sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

Annett says recently, OncoCyte released positive data on its lung cancer diagnostic study.

 
View full OCX profile View Profile

OncoCyte Corporation Timeline

Video
February 11 2019
OncoCyte releases positive data on lung cancer diagnostic study
Article
January 29 2019
OncoCyte shares more than triple on rosy data from key biopsy test for lung cancer
Video
October 18 2018
OncoCyte looks to begin R&D validation stage for its cancer diagnostics test
Article
July 10 2018
OncoCyte shares soar on results from its cancer diagnostic blood test DetermaVu
View All Stories
Partners:
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use